InChIKey	PGBHMTALBVVCIT-VCIWKGPPSA-N
Compound Name	Neomycin
Canonical SMILES	NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	59
Pfam Stratification	Cross-Family
Avg pChEMBL	7.45
Source	BindingDB;ChEMBL

DrugBank ID	DB00452
Drug Name	Framycetin
CAS Number	119-04-0
Groups	approved investigational
ATC Codes	D09AA01 R01AX08 S01AA07
Description	A component of neomycin that is produced by Streptomyces fradiae. On hydrolysis it yields neamine and neobiosamine B. (From Merck Index, 11th ed)

---

Categories: Agents that produce neuromuscular block (indirect) Aminoglycoside Antibacterials Anti-Bacterial Agents Anti-Infective Agents Carbohydrates Dermatologicals Glycosides Medicated Dressings Medicated Dressings With Antiinfectives Nasal Preparations Nephrotoxic agents Ophthalmologicals Sensory Organs

---

Cross-references: BindingDB: 19 ChEBI: 7508 CHEMBL184618 ChemSpider: 8075 Drugs Product Database (DPD): 8626 C01737 D05140 PDB: NMY PharmGKB: PA164743181 PubChem:8378 PubChem:46508892 RxCUI: 4556 Therapeutic Targets Database: DNC001005 Wikipedia: Neomycin ZINC: ZINC000071928291